Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Magro

Showing results (331-340 of 341) with videos related to

Pageof 35
Sort By:
United European Gastroenterology Journal|July 28, 2020
The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD studyJohan Burisch, Daniel Bergemalm, Jonas Halfvarson, et al.
Journal of Crohn'S & Colitis|October 6, 2018
Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD StudyJohan Burisch, Konstantinos H Katsanos, Dimitrios K Christodoulou, et al.
United European Gastroenterology Journal|January 18, 2025
Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey StudyOffir Ukashi, Aurelien Amiot, David Laharie, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2020
Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based studyJohan Burisch, Hillel Vardi, Doron Schwartz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 30, 2026
Ustekinumab and JAK inhibitors outperform vedolizumab as second-line therapy in anti-TNF-experienced patients with ulcerative colitisGiuseppe Privitera, Cristina Bezzio, Gisella Figlioli, et al.
Inflammatory Bowel Diseases|December 2, 2014
Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom StudyJohan Burisch, Hillel Vardi, Natalia Pedersen, et al.
Journal of Crohn'S & Colitis|June 3, 2017
Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort-An ECCO-EpiCom StudyJohan Burisch, Zsuzsanna Vegh, Konstantinnos H Katsanos, et al.
Gastroenterology|May 30, 2025
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel DiseaseJurij Hanžel, Virginia Solitano, Sudheer Kumar Vuyyuru, et al.
Gastroenterology|July 5, 2022
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease, Christopher Ma, Jurij Hanzel, et al.
Journal of Crohn'S & Colitis|May 23, 2018
Diagnostic Yield of Next-generation Sequencing in Very Early-onset Inflammatory Bowel Diseases: A Multicentre StudyFabienne Charbit-Henrion, Marianna Parlato, Sylvain Hanein, et al.
Pageof 35

Showing results (331-340 of 341) with videos related to

Sort By:
Pageof 35
United European Gastroenterology Journal|July 28, 2020
The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD studyJohan Burisch, Daniel Bergemalm, Jonas Halfvarson, et al.
Journal of Crohn'S & Colitis|October 6, 2018
Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD StudyJohan Burisch, Konstantinos H Katsanos, Dimitrios K Christodoulou, et al.
United European Gastroenterology Journal|January 18, 2025
Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey StudyOffir Ukashi, Aurelien Amiot, David Laharie, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2020
Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based studyJohan Burisch, Hillel Vardi, Doron Schwartz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 30, 2026
Ustekinumab and JAK inhibitors outperform vedolizumab as second-line therapy in anti-TNF-experienced patients with ulcerative colitisGiuseppe Privitera, Cristina Bezzio, Gisella Figlioli, et al.
Inflammatory Bowel Diseases|December 2, 2014
Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom StudyJohan Burisch, Hillel Vardi, Natalia Pedersen, et al.
Journal of Crohn'S & Colitis|June 3, 2017
Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort-An ECCO-EpiCom StudyJohan Burisch, Zsuzsanna Vegh, Konstantinnos H Katsanos, et al.
Gastroenterology|May 30, 2025
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel DiseaseJurij Hanžel, Virginia Solitano, Sudheer Kumar Vuyyuru, et al.
Gastroenterology|July 5, 2022
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease, Christopher Ma, Jurij Hanzel, et al.
Journal of Crohn'S & Colitis|May 23, 2018
Diagnostic Yield of Next-generation Sequencing in Very Early-onset Inflammatory Bowel Diseases: A Multicentre StudyFabienne Charbit-Henrion, Marianna Parlato, Sylvain Hanein, et al.
Pageof 35